Consistent with these results, immunohistochemistry staining revealed that Stim1 is far more abundant in human hepatocarcinoma in comparison to surrounding healthy tissues [58], while Stim2 transcripts are augmented in human colorectal cancer [25] and human glioblastoma puntiforme [59]. The gene discussed is STIM2; the disease is colorectal cancer.